Prostate carcinogenesis in N-methyl-N-nitrosourea (NMU)-testosterone-treated rats fed tomato powder, lycopene, or energy-restricted diets.

BACKGROUND Consumption of tomato products or lycopene and energy restriction have been hypothesized to reduce the risk of human prostate cancer. We investigated the effects of these dietary variables in a rat model of prostate carcinogenesis. METHODS Male rats (n = 194) treated with N-methyl-N-nitrosourea and testosterone to induce prostate cancer were fed diets containing whole tomato powder (13 mg lycopene/kg diet), lycopene beadlets (161 mg lycopene/kg diet), or control beadlets. Rats in each group were randomly assigned to either ad libitum feeding or 20% diet restriction. Differences between Kaplan-Meier survival curves for diet composition or restriction were tested with the log-rank test. Cox proportional hazards models were developed to examine the combined effect of diet composition and restriction on survival. Statistical tests were two-sided. RESULTS Risk of death with prostate cancer was lower for rats fed the tomato powder diet than for rats fed control beadlets (hazard ratio [HR] = 0.74, 95% confidence interval [CI] = 0.59 to 0.93; P =.009). In contrast, prostate cancer-specific mortality of the control and lycopene-fed rats was similar (P =.63). The proportions of rats dying with prostate cancer in the control, lycopene, and tomato powder groups were 80% (95% CI = 68% to 89%), 72% (95% CI = 60% to 83%), and 62% (95% CI = 48% to 75%), respectively. Rats in the diet-restricted group experienced longer prostate cancer-free survival than rats in the ad libitum-fed group (HR = 0.68, 95% CI = 0.49 to 0.96; P =.029). The proportion of rats that developed prostate cancer was 79% (95% CI = 69% to 86%) for ad libitum-fed rats and 65% (95% CI = 54% to 74%) for rats fed restricted diets. No interactions were observed between diet composition and dietary restriction. CONCLUSIONS Consumption of tomato powder but not lycopene inhibited prostate carcinogenesis, suggesting that tomato products contain compounds in addition to lycopene that modify prostate carcinogenesis. Diet restriction also reduced the risk of prostate cancer. Tomato phytochemicals and diet restriction may act by independent mechanisms.

[1]  F. Khachik,et al.  Tomatoes or lycopene versus prostate cancer: is evolution anti-reductionist? , 2003, Journal of the National Cancer Institute.

[2]  S. Clinton,et al.  Tomato and soy polyphenols reduce insulin-like growth factor-I-stimulated rat prostate cancer cell proliferation and apoptotic resistance in vitro via inhibition of intracellular signaling pathways involving tyrosine kinase. , 2003, The Journal of nutrition.

[3]  R. Russell,et al.  Lycopene supplementation inhibits lung squamous metaplasia and induces apoptosis via up-regulating insulin-like growth factor-binding protein 3 in cigarette smoke-exposed ferrets. , 2003, Cancer research.

[4]  E. Giovannucci.  A Review of Epidemiologic Studies of Tomatoes, Lycopene, and Prostate Cancer , 2002, Experimental biology and medicine.

[5]  R. Kraaij,et al.  Validation of transrectal ultrasonographic volumetry for orthotopic prostate tumours in mice , 2002, Laboratory animals.

[6]  E. Rimm,et al.  A prospective study of tomato products, lycopene, and prostate cancer risk. , 2002, Journal of the National Cancer Institute.

[7]  R. V. van Breemen,et al.  Liquid chromatography-mass spectrometry of cis- and all-trans-lycopene in human serum and prostate tissue after dietary supplementation with tomato sauce. , 2002, Journal of agricultural and food chemistry.

[8]  R. V. van Breemen,et al.  Oxidative DNA damage in prostate cancer patients consuming tomato sauce-based entrees as a whole-food intervention. , 2001, Journal of the National Cancer Institute.

[9]  K. Miyashita,et al.  Carotenoids affect proliferation of human prostate cancer cells. , 2001, The Journal of nutrition.

[10]  M. Banerjee,et al.  Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[11]  J. Erdman,et al.  Testosterone and food restriction modulate hepatic lycopene isomer concentrations in male F344 rats. , 2001, The Journal of nutrition.

[12]  M. Thun,et al.  Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[13]  C. Friedenreich,et al.  Physical activity and cancer prevention: from observational to intervention research. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[14]  Y. Chen,et al.  Quercetin inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells. , 2001, Carcinogenesis.

[15]  N. Fleshner,et al.  Serum and tissue lycopene and biomarkers of oxidation in prostate cancer patients: a case control study , 2000, Prostate Cancer and Prostatic Diseases.

[16]  E. Castanas,et al.  Wine Antioxidant Polyphenols Inhibit the Proliferation of Human Prostate Cancer Cell Lines , 2000, Nutrition and cancer.

[17]  J. Erdman,et al.  Tissue lycopene concentrations and isomer patterns are affected by androgen status and dietary lycopene concentration in male F344 rats. , 2000, The Journal of nutrition.

[18]  K. Yeum,et al.  Tissue distribution of lycopene in ferrets and rats after lycopene supplementation. , 2000, The Journal of nutrition.

[19]  J. Erdman,et al.  Beta-carotene modulates human prostate cancer cell growth and may undergo intracellular metabolism to retinol. , 2000, The Journal of nutrition.

[20]  A. Kristal,et al.  Invited commentary: tomatoes, lycopene, and prostate cancer. How strong is the evidence? , 2000, American journal of epidemiology.

[21]  V. Freeman,et al.  Prostatic levels of tocopherols, carotenoids, and retinol in relation to plasma levels and self-reported usual dietary intake. , 2000, American journal of epidemiology.

[22]  M. Karas,et al.  Lycopene Interferes With Cell Cycle Progression and Insulin-Like Growth Factor I Signaling in Mammary Cancer Cells , 2000, Nutrition and cancer.

[23]  Judith D. Goldberg,et al.  Applied Survival Analysis , 1999, Technometrics.

[24]  R. Weindruch,et al.  Effect of antioxidants on androgen-induced AP-1 and NF-kappaB DNA-binding activity in prostate carcinoma cells. , 1999, Journal of the National Cancer Institute.

[25]  V. Steele,et al.  Chemoprevention of rat prostate carcinogenesis by early and delayed administration of dehydroepiandrosterone. , 1999, Cancer research.

[26]  M. Bosland.  Use of Animal Models in Defining Efficacy of Chemoprevention Agents against Prostate Cancer , 1999, European Urology.

[27]  W. J. Visek,et al.  Energy intake and prostate tumor growth, angiogenesis, and vascular endothelial growth factor expression. , 1999, Journal of the National Cancer Institute.

[28]  W. Willett,et al.  Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. , 1999, Cancer research.

[29]  E. Giovannucci,et al.  Tomatoes, tomato-based products, lycopene, and cancer: review of the epidemiologic literature. , 1999, Journal of the National Cancer Institute.

[30]  V. Steele,et al.  Chemoprevention of rat prostate carcinogenesis by 9-cis-retinoic acid. , 1999, Cancer research.

[31]  N. Fleshner,et al.  Serum and tissue lycopene and biomarkers of oxidation in prostate cancer patients: a case-control study. , 1999, Nutrition and cancer.

[32]  S. Clinton,et al.  Lycopene: chemistry, biology, and implications for human health and disease. , 2009, Nutrition reviews.

[33]  A. Azzi,et al.  Lycopene in association with alpha-tocopherol inhibits at physiological concentrations proliferation of prostate carcinoma cells. , 1998, Biochemical and biophysical research communications.

[34]  Morris Pollard,et al.  Lobund‐Wistar rat model of prostate cancer in man , 1998, The Prostate.

[35]  V. Steele,et al.  Influence of N-methyl-N-nitrosourea, testosterone, and N-(4-hydroxyphenyl)-all-trans-retinamide on prostate cancer induction in Wistar-Unilever rats. , 1998, Cancer research.

[36]  D. Bostwick,et al.  Workgroup I: Rodent models of prostate cancer , 1998, The Prostate.

[37]  L. Seethalakshmi,et al.  Effect of vitamin C on androgen independent prostate cancer cells (PC3 and Mat-Ly-Lu) in vitro: involvement of reactive oxygen species-effect on cell number, viability and DNA synthesis. , 1998, Cancer biochemistry biophysics.

[38]  F. Khachik,et al.  Lycopene Uptake and Tissue Disposition in Male and Female Rats 1 , 1998, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[39]  G. Beecher.  Nutrient Content of Tomatoes and Tomato Products , 1998, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[40]  M. Menon,et al.  Effect of vitamin C on prostate cancer cells in vitro: Effect on cell number, viability, and DNA synthesis , 1997, The Prostate.

[41]  W. J. Visek,et al.  Dietary fat and protein intake differ in modulation of prostate tumor growth, prolactin secretion and metabolism, and prostate gland prolactin binding capacity in rats. , 1997, The Journal of nutrition.

[42]  J. Gilloteaux,et al.  SYNERGISTIC ANTITUMOUR ACTIVITY OF VITAMINS C AND K3AGAINST HUMAN PROSTATE CARCINOMA CELL LINES , 1996, Cell biology international.

[43]  D. Bostwick,et al.  cis-trans lycopene isomers, carotenoids, and retinol in the human prostate. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[44]  J. Ward,et al.  High Incidence and Histogenesis of Seminal Vesicle Adenocarcinoma and Lower Incidence of Prostate Carcinomas in the Lobund-Wistar Prostate Cancer Rat Model Using N-nitrosomethylurea and Testosterone , 1996, Veterinary pathology.

[45]  S. Mayne,et al.  Beta‐carotene, carotenoids, and disease prevention in humans , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[46]  G A Colditz,et al.  Intake of carotenoids and retinol in relation to risk of prostate cancer. , 1995, Journal of the National Cancer Institute.

[47]  F. Böhm,et al.  Carotenoids protect against cell membrane damage by the nitrogen dioxide radical , 1995, Nature Medicine.

[48]  M. Danilenko,et al.  Lycopene is a more potent inhibitor of human cancer cell proliferation than either alpha-carotene or beta-carotene. , 1995, Nutrition and cancer.

[49]  P. G. Reeves,et al.  AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. , 1993, The Journal of nutrition.

[50]  Peter C. H. Hollman,et al.  Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in the Netherlands , 1992 .

[51]  M. Bosland.  Animal models for the study of prostate carcinogenesis , 1992, Journal of cellular biochemistry. Supplement.

[52]  J. Bertram,et al.  Carotenoids enhance gap junctional communication and inhibit lipid peroxidation in C3H/10T1/2 cells: relationship to their cancer chemopreventive action. , 1991, Carcinogenesis.

[53]  B. Polk,et al.  Serologic precursors of cancer. Retinol, carotenoids, and tocopherol and risk of prostate cancer. , 1990, Journal of the National Cancer Institute.

[54]  P. Di Mascio,et al.  Lycopene as the most efficient biological carotenoid singlet oxygen quencher. , 1989, Archives of biochemistry and biophysics.

[55]  W. L. Beeson,et al.  Cohort study of diet, lifestyle, and prostate cancer in adventist men , 1989, Cancer.

[56]  R. Brookmeyer,et al.  Serologic precursors of cancer. I. Prediagnostic serum nutrients and colon cancer risk. , 1987, American journal of epidemiology.

[57]  S. Peller.  Cancer in man , 1952 .